28 | Peptides (Polypeptides)IBA
01/2017
-
01/2003 |
16 | HaptensIBA
02/2015
-
11/2005 |
13 | Ethanol (Ethyl Alcohol)IBA
01/2018
-
09/2002 |
10 | Carcinoembryonic AntigenIBA
01/2017
-
10/2005 |
8 | Radioisotopes (Radionuclides)IBA
01/2017
-
01/2003 |
7 | Monoclonal AntibodiesIBA
01/2017
-
09/2003 |
7 | Immunoglobulin G (IgG)IBA
11/2015
-
10/2005 |
7 | AntibodiesIBA
06/2012
-
09/2003 |
6 | Histamine (Histamine Dihydrochloride)FDA Link
01/2017
-
11/2005 |
6 | Glycine (Aminoacetic Acid)FDA LinkGeneric
01/2017
-
11/2005 |
6 | AntigensIBA
02/2015
-
01/2003 |
5 | NicotineFDA Link
06/2019
-
05/2012 |
5 | DOTA- tyrosyl- lysyl(histaminyl- succinyl- glycyl)- glutamyl- lysyl(histaminyl- succinyl- glycyl)amideIBA
01/2017
-
04/2010 |
5 | AcidsIBA
02/2010
-
09/2003 |
5 | salsolinolIBA
02/2010
-
01/2002 |
4 | Dopamine (Intropin)FDA LinkGeneric
02/2015
-
02/2008 |
4 | Pentetic Acid (DTPA)FDA LinkGeneric
02/2010
-
09/2003 |
3 | procaine isothiocyanate (PRIT)IBA
01/2017
-
11/2010 |
3 | Bispecific AntibodiesIBA
02/2015
-
10/2005 |
3 | Therapeutic UsesIBA
12/2012
-
09/2003 |
3 | Fluorodeoxyglucose F18 (Fludeoxyglucose F 18)FDA Link
01/2012
-
10/2006 |
3 | AcetaldehydeIBA
02/2010
-
01/2002 |
2 | RNA (Ribonucleic Acid)IBA
01/2018
-
02/2015 |
2 | 1,4,7,10-tetraazacyclododecane- 1,4,7,10-tetraacetic acidIBA
01/2017
-
11/2014 |
2 | Proteins (Proteins, Gene)FDA Link
01/2016
-
01/2004 |
2 | Immunoconjugates (Immunoconjugate)IBA
11/2015
-
06/2015 |
2 | Irinotecan (Camptosar)FDA LinkGeneric
11/2015
-
06/2015 |
2 | Bombesin Receptors (Bombesin Receptor)IBA
12/2014
-
06/2012 |
2 | A-factor (Streptomyces)IBA
02/2008
-
03/2003 |
2 | Immunoglobulin Fab FragmentsIBA
05/2006
-
10/2005 |
1 | Atrial Natriuretic Factor (ANF)IBA
12/2020 |
1 | CannabinoidsIBA
10/2020 |
1 | Hemoglobins (Hemoglobin)IBA
01/2017 |
1 | CreatinineIBA
01/2017 |
1 | Glutamic Acid (Glutamate)FDA Link
01/2016 |
1 | EnzymesIBA
01/2016 |
1 | Neurotransmitter Agents (Neurotransmitter)IBA
01/2016 |
1 | Glutamate Receptors (Glutamate Receptor)IBA
01/2016 |
1 | sacituzumab govitecanIBA
11/2015 |
1 | labetuzumab govitecanIBA
06/2015 |
1 | Topoisomerase I InhibitorsIBA
06/2015 |
1 | labetuzumabIBA
06/2015 |
1 | Bevacizumab (Avastin)FDA Link
06/2015 |
1 | CotinineIBA
02/2015 |
1 | IntegrinsIBA
05/2013 |
1 | 1- (1,3- carboxypropyl)- 4,7- carboxymethyl- 1,4,7- triazacyclononaneIBA
05/2013 |
1 | arginyl-glycyl-aspartic acidIBA
05/2013 |
1 | Phosphates (Orthophosphate)IBA
12/2012 |
1 | Immunoglobulin FragmentsIBA
06/2012 |
1 | IsotopesIBA
06/2012 |
1 | BombesinIBA
06/2012 |
1 | Cocaine (Cocaine HCl)IBA
10/2011 |
1 | Neoplasm Antigens (Tumor Antigens)IBA
05/2010 |
1 | Somatostatin Receptors (Somatostatin Receptor)IBA
03/2010 |
1 | clivatuzumabIBA
12/2009 |
1 | MucinsIBA
12/2009 |
1 | EpitopesIBA
12/2009 |
1 | GemcitabineFDA Link
12/2009 |
1 | Antiviral Agents (Antivirals)IBA
10/2009 |
1 | triazacyclononaneIBA
06/2009 |
1 | 1,4,7- triazacyclononane- N,N',N''- triacetic acid (NOTA)IBA
06/2009 |
1 | Inosine Monophosphate (IMP)IBA
06/2009 |
1 | SolutionsIBA
06/2009 |
1 | veltuzumabIBA
03/2009 |
1 | peptide 74IBA
03/2009 |
1 | CatecholaminesIBA
03/2008 |
1 | FluorineIBA
02/2008 |
1 | Fibronectins (Fibronectin)IBA
09/2006 |
1 | Naltrexone (ReVia)FDA LinkGeneric
01/2006 |
1 | N-acetylphenylalanyllysineIBA
10/2005 |